The global empty capsules market size was valued at USD 3.82 billion in 2023 and is projected to grow at a CAGR of 3.8% from 2024 to 2030. The growth in the capsule market can be attributed to several key factors such as the rise in the geriatric population led to increased demand for medications. Growing consumers prefer capsules over tablets as they are easy to swallow and have faster dissolution rates than other medicines. The high demand for capsules in the pharmaceutical, nutraceutical, and cosmeceutical industries is also driving the market.
Many consumers prefer capsules as they disintegrate quickly, allowing for faster absorption. Additionally, the tasteless and odorless gelatin coating makes these capsules more edible. Most nutraceuticals and cosmeceuticals prefer medicine in capsule form, as encapsulated medications enhance the bioavailability of specific active ingredients by protecting them from the harsh conditions of the gastrointestinal tract. Furthermore, capsules can be custom-designed to release the active ingredient to a particular location in the body or slowly over a certain timeframe, enhancing drug absorption.
Another key factor driving the empty capsule market is that capsules act faster than tablets. Capsules can have a higher bioavailability, which means more medication enters the bloodstream, making it slightly more effective than tablets. Additionally, capsules deliver not only solid but also liquid medicine dosage, making it more favorable to consume.
Gelatin dominated the market and accounted for a revenue share of 73.5% in 2023. The gelatin-based empty capsule products include pig meat gelatin, bovine-derived gelatin, bone meal gelatin, and others. These capsules are pure protein, tasteless, gluten-free, and GMO-free. It can be customized by adjusting color, shape, or size to meet specific requirements and cater to different demographics.
The non-gelatin capsules segment is expected to grow at the fastest CAGR over the forecast period. There are two main types of non-gelatin capsules: HPMC, which is made from cellulose, and pullulan, which is extracted from tapioca roots. Non-gelatin capsules are becoming more popular as they are sourced from vegetable cellulose. It is an alternative to gelatin or non-vegetarian capsules, particularly when developing vegan or vegetarian products.
The antibiotic and antibacterial drugs segment dominated the market and accounted for the largest revenue share in 2023. Some commonly used antibacterial drugs are penicillin, tetracycline, sulfonamide, nitrofurantoin, and others. Increasing bacterial infections, tuberculosis, bladder infections, and gastrointestinal infections are expected to generate greater demand for antibiotic and antibacterial drugs. In addition, increasing research and development activities related to antibiotic and antibacterial drugs are assisting the market growth.
Vitamins and dietary supplements are expected to experience the fastest CAGR during the forecast period. This is primarily due to factors such as the growing consumption of vitamins and dietary supplements, the ease of use associated with them, increasing acceptance of dietary supplements, the rising need for vitamin products caused by lifestyle changes, and growing awareness about health and fitness, leading to an upsurge in demand for such products.
The pharmaceutical segment accounted for a revenue share of in 2023. Empty capsules are widely used in the pharmaceutical industry to treat infectious and chronic diseases. These capsules expand the shelf life of the drug's active ingredients. The pharmaceutical segment is growing as a huge variety of drugs are being made and used by health practitioners.
The nutraceutical segment is projected to grow at the fastest CAGR over the forecast period. These generic, non-specific biological drugs promote general well-being and control general deficiency symptoms. Probiotics, Green Tea Supplements, Vitamin B12 capsules, and omega-3 Fatty Acids are commonly used nutraceutical products. The cosmeceutical segment is also rapidly growing as customers seek products that offer both cosmetics and pharmaceutical benefits. Additionally, empty capsules are widely used in research laboratories to store chemicals.
North America empty capsules market dominated the global market with a revenue share of 34.7% in 2023. North America has major capsule manufacturing units and a huge production capacity. The North American region has the presence of various pharmaceutical companies. The region has the most advanced technologies concerning the pharmaceutical industry, which is the major reason for propelling region growth.
The U.S. empty capsule market dominated the North American market in 2023 due to increased health problems such as cancer, obesity, and arthritis, which created a high demand for nutraceuticals to prevent such major issues. Additionally, rising consumer preferences for customized dietary supplements and health solutions, which are easily formulated and consumed in capsules compared to tablets or powders, are further driving the market growth.
Europe's empty capsules market was identified as a lucrative region in 2023. The region's robust pharmaceutical sector and many multinational companies and research institutions significantly drive the empty capsules market. Europe has a strong regulatory system for pharmaceuticals, ensuring high-quality standards for the empty capsules market.
The UK empty capsules market is expected to grow rapidly in the coming years due to innovations in capsule technology, such as biodegradable and sustainable options, attracting consumer and manufacturer interest. The aging population and increasing prevalence of chronic diseases, such as diabetes and heart disease, are leading to a higher demand for medications, which often require empty capsules.
Asia Pacific's empty capsules market is expected to grow at the fastest CAGR over the forecast period. The factors driving the market growth are favorable government initiatives, the proliferation of pharmaceutical industries, and rapid development in the healthcare sector. Furthermore, the growing demand for healthy lifestyles and increasing trends in nutraceuticals and cosmeceuticals favor market growth.
The China empty capsules market held a substantial market share in 2023. China is a major manufacturing hub with a vast network of pharmaceutical and nutraceutical companies that rely heavily on empty capsules for their product formulations. Developing cost-effective, high-quality empty capsule manufacturing facilities drives the country's market. Furthermore, the Chinese government's supportive policies, such as incentives for pharmaceutical manufacturing and investments in healthcare infrastructure, have created a favorable environment for the empty capsules market to grow.
Some key companies in the empty capsules market include Bright Pharma Caps, Lonza, Qualicaps, HealthCaps India Ltd, and others. These companies are implementing new technologies, mergers and acquisitions, and innovations to enhance their position in the global market for empty capsules.
The following are the leading companies in the empty capsules market. These companies collectively hold the largest market share and dictate industry trends.
Report Attribute |
Details |
Market size value in 2024 |
USD 3.97 billion |
Revenue forecast in 2030 |
USD 4.97 billion |
Growth Rate |
CAGR of 3.8% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, therapeutic application, end use, and region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, MEA |
Country scope |
U.S., Canada, Mexico, Germany, UK, France, Italy, Spain, Denmark, Sweden, Norway, China, Japan, India, South Korea, Australia, Thailand, Brazil, Argentina, UAE, and South Africa, Saudi Arabia, Kuwait |
Key companies profiled |
Bright Pharma Caps; Lonza; Qualicaps; HealthCaps India Ltd; Dun & Bradstreet, Inc. (Shanxi JC Biological Technology Co. Ltd); ACG; Medi-Caps Ltd; Suheung; capsCanada Corporation |
Customization scope |
Free report customization (equivalent up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global empty capsules market report based on product, therapeutic application, end use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Gelatin
Pig Meat Gelatin
Bovine Derived
Bone Meal
Other Gelatin Capsule Products
Non-Gelatin
Therapeutic Application Outlook (Revenue, USD Million, 2018 - 2030)
Antibiotic and Antibacterial Drugs
Vitamins and Dietary Supplements
Antacid and Antiflatulent Preparations
Antianemic Preparations (Hematenic Preparations)
Anti-Inflammatory Drugs
Cardiovascular Therapy Drugs
Cough and Cold Preparations
Other therapeutic applications
End Use Outlook (Revenue, USD Million, 2018- 2030)
Pharmaceutical
Nutraceutical
Cosmeceutical
Research Laboratories
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
UAE
Saudi Arabia
Kuwait
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."